PMAP-36 (2-17), RI16

General Information


DRACP ID  DRACP03549

Peptide Name   PMAP-36 (2-17), RI16

Sequence  RFRRLRKKTRKRLKKI

Sequence Length  16

UniProt ID  P49931 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03549

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C97H183N39O18

Absent amino acids  ACDEGHMNPQSVWY

Common amino acids  R

Mass  245148

Pl  13.21

Basic residues  11

Acidic residues  0

Hydrophobic residues  4

Net charge  11

Boman Index  -10210

Hydrophobicity  -201.88

Aliphatic Index  73.13

Half Life 
  Mammalian: 2.8 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25494332

Title  Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide

Doi Not available

Year  2014

Literature 2

Pubmed ID 24021230

Title  Design of imperfectly amphipathic ?-helical antimicrobial peptides with enhanced cell selectivity

Doi Not available

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  7143

DRACP is developed by Dr.Zheng's team.